✦ LIBER ✦

SS-11-3 Clinical trial of aldose reductase inhibitor (Epalrestat) in diabetic polyneuropathy: electrophysiological evaluation

✍ Scribed by Mari Katayama; Ryuji Kaji; Nobuo Kohara; Yasuhiro Kojima; Nobuyuki Hirota; Tamotsu Kubori; Hiroshi Shibasaki; Jun Kimura

Book ID: 116159145
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 119 KB
Volume: 97
Category: Article
ISSN: 0924-980X
DOI: 10.1016/0924-980x(95)92709-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Clinical Effects of Epalrestat

Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

✍ Hotta, N.; Akanuma, Y.; Kawamori, R.; Matsuoka, K.; Oka, Y.; Shichiri, M.; Toyot 📂 Article 📅 2006 🏛 American Diabetes Association 🌐 English ⚖ 225 KB